This data comes from the presentation, “Radiation Enhances Anti-Tumor Activity of Checkpoint Blockade in Syngeneic Tumor Models” by Covance researchers Sumithra Urs, Mary Anne Meade, Kevin Guley, Sarah Krueger, Alden Wong, Scott Wise, and Maryland Rosenfeld Franklin. SARRP enables researchers to perform targeted focal irradiation, allowing researchers to evaluate radiation therapy efficacy alone and with immunomodulatory therapies.
See the original presentation here.
Contact Us
Xstrahl presented The role of radiation technologists as a radiotherapy treatment at the 11th Congress of Radiological Technologists of R. N. Macedonia
Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will demonstrate Xstrahl 200, a modern orthovoltage radiotherapy solution for treating superficial lesions, skin cancers, and selective benign conditions at the 2024 American Society for Therapeutic Radiology and Oncology (ASTRO) Annual Meeting in Washington, DC Sept. 29-Oct 2, 2024, at booth #1937.
Xstrahl, the leader in preclinical radiation research systems, will demonstrate SmART-RAD at the 70th Annual Meeting of the Radiation Research Society (RRS) at the Westin La Paloma Resort & Spa, in Tucson, AZ, Sept. 15-18.
